Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$3.38
0.082.42%
At close: Sep 11, 5:00 PM EST
$3.48
0.102.96%
After Hours: Sep 11, 5:20 PM EST
Kalaris Therapeutics Inc (KLRS) Stock Price, Quote, News & History
KLRSNASDAQ
Kalaris Therapeutics (KLRS) Stock Price, Quote, News & History | Benzinga
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Kalaris Therapeutics (KLRS) stock?
You can purchase shares of Kalaris Therapeutics (NASDAQ:KLRS) through any online brokerage.
Who are Kalaris Therapeutics (KLRS) competitors?
Other companies in Kalaris Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
What is the forecast, or price target, for Kalaris Therapeutics (KLRS) stock?
Kalaris Therapeutics has a consensus price target of $19.60.
What is the current price for Kalaris Therapeutics (KLRS)?
The stock price for Kalaris Therapeutics (NASDAQ: KLRS) is $3.48 last updated September 11, 2026 at 5:20 PM EDT.
Does Kalaris Therapeutics (KLRS) pay a dividend?
There are no upcoming dividends for Kalaris Therapeutics.
When is Kalaris Therapeutics (NASDAQ:KLRS) reporting earnings?
Kalaris Therapeutics does not have any upcoming earnings scheduled.
Is Kalaris Therapeutics (KLRS) going to split?
There is no upcoming split for Kalaris Therapeutics.
What sector and industry does Kalaris Therapeutics (KLRS) operate in?
Kalaris Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
